PARADIGM ASSET MANAGEMENT CO LLC
Position in IDXX — Idexx Laboratories Inc /De
CIK 1034549
NEW YORK, NY
Position in IDXX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$157,932
-$6,186 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,037
of 1,286 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PARADIGM ASSET MANAGEMENT CO LLC holds $2,921,442 across 7 Diagnostics & Research names. IDXX ranks #3 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
6,300 | $1,335,285 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,300 | $1,153,128 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
This page
|
300 | $157,932 | |
| 4 | LH |
Labcorp Holdings Inc.
|
501 | $140,280 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
398 | $76,901 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
176 | $39,915 | |
| 7 | WAT |
Waters Corp /De/
|
48 | $18,001 |
All Filings in IDXX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157,932 | 300 | Shares | Sole | 2026-08-06 | |
| 2022-03-31 | $164,118 | 300 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $197,538 | 300 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $186,570 | 300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $252,620 | 400 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $244,655 | 500 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $299,922 | 600 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||